Blackstone Inc
PACB icon

Blackstone Inc’s Pacific Biosciences PACB Stock Holding History

Blackstone Inc’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,000,000
Closed -$8.35M – 174
2023
Q3 		$8.35M Hold
1,000,000
– – 0.04% 84
2023
Q2 		$13.3M Hold
1,000,000
– – 0.06% 70
2023
Q1 		$11.6M Buy
+1,000,000
New +$9.94M 0.05% 72
2020
Q4 		– Sell
-2,411,556
Closed -$23.8M – 261
2020
Q3 		$23.8M Hold
2,411,556
– – 0.09% 61
2020
Q2 		$8.32M Hold
2,411,556
– – 0.04% 78
2020
Q1 		$7.38M Hold
2,411,556
– – 0.05% 45
2019
Q4 		$12.4M Hold
2,411,556
– – 0.08% 29
2019
Q3 		$12.4M Hold
2,411,556
– – 0.07% 32
2019
Q2 		$14.6M Hold
2,411,556
– – 0.08% 34
2019
Q1 		$17.4M Hold
2,411,556
– – 0.08% 33
2018
Q4 		$17.8M Hold
2,411,556
– – 0.1% 25
2018
Q3 		$13M Hold
2,411,556
– – 0.06% 24
2018
Q2 		$8.56M Sell
2,411,556
-1,712,015
-42% -$4.75M 0.04% 29
2018
Q1 		$8.45M Buy
4,123,571
+1,712,015
+71% +$4.45M 0.04% 34
2017
Q4 		$6.37M Hold
2,411,556
– – 0.03% 74
2017
Q3 		$12.7M Hold
2,411,556
– – 0.08% 20
2017
Q2 		$8.59M Hold
2,411,556
– – 0.08% 26
2017
Q1 		$12.5M Hold
2,411,556
– – 0.1% 28
2016
Q4 		$9.16M Hold
2,411,556
– – 0.06% 27
2016
Q3 		$21.6M Hold
2,411,556
– – 0.12% 36
2016
Q2 		$17M Hold
2,411,556
– – 0.08% 63
2016
Q1 		$20.5M Hold
2,411,556
– – 0.09% 43
2015
Q4 		$31.7M Hold
2,411,556
– – 0.12% 39
2015
Q3 		$8.83M Hold
2,411,556
– – 0.03% 50
2015
Q2 		$13.9M Hold
2,411,556
– – 0.04% 43
2015
Q1 		$14.1M Hold
2,411,556
– – 0.04% 30
2014
Q4 		$18.9M Hold
2,411,556
– – 0.05% 36
2014
Q3 		$11.8M Hold
2,411,556
– – 0.03% 33
2014
Q2 		$14.9M Hold
2,411,556
– – 0.05% 27
2014
Q1 		$12.9M Hold
2,411,556
– – 0.04% 28
2013
Q4 		$12.6M Hold
2,411,556
– – 0.04% 25
2013
Q3 		$13.3M Hold
2,411,556
– – 0.11% 25
2013
Q2 		$6.1M Buy
+2,411,556
New +$6M 0.05% 30

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Blackstone Inc's PACB Position: Q4 2023 in Review

Blackstone Inc sold out of Pacific Biosciences (PACB) in Q4 2023, closing a stake of 1,000,000 shares — an estimated $8.35M sold.

Blackstone Inc first reported a position in PACB in Q2 2013 and held it in 33 quarters. The position peaked at $31.7M in Q4 2015. 274 funds tracked by Wall St. Rank hold PACB as of Q4 2023.

  • Blackstone Inc reported no remaining Pacific Biosciences position as of Q4 2023 after selling out during the quarter.
  • Blackstone Inc sold 1,000,000 Pacific Biosciences shares in Q4 2023, an estimated $8.35M.
  • Blackstone Inc first reported a position in Pacific Biosciences in Q2 2013 and held it in 33 quarters.
  • Blackstone Inc's Pacific Biosciences position peaked at $31.7M in Q4 2015.
  • 274 funds tracked by Wall St. Rank held Pacific Biosciences as of Q4 2023.

Based on Blackstone Inc's 13F filing for Q4 2023, filed 14 Feb 2024.